Sign In
Buy BEAT
$0.501
-0.0166 (-3.21%)
At Close: Jul 31, 2026
Sidoti Cuts BioTelemetry (NASDAQ:BEAT) Price Target to $75.00
11:26am, Monday, 02'nd Mar 2020
BioTelemetry (NASDAQ:BEAT) had its target price reduced by Sidoti from $81.00 to $75.00 in a research report report published on Thursday morning, BenzingaRatingsTable reports. Sidoti currently has a
6,450 Shares in BioTelemetry Inc (NASDAQ:BEAT) Acquired by Banque Cantonale Vaudoise
10:36am, Monday, 02'nd Mar 2020
Banque Cantonale Vaudoise acquired a new position in shares of BioTelemetry Inc (NASDAQ:BEAT) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities an
Altshuler Shaham Ltd Has $246,000 Position in BioTelemetry Inc (NASDAQ:BEAT)
10:14am, Monday, 02'nd Mar 2020
Altshuler Shaham Ltd raised its stake in BioTelemetry Inc (NASDAQ:BEAT) by 8.2% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 5,300 shares of the medical researc
Short Interest in BioTelemetry Inc (NASDAQ:BEAT) Rises By 7.4%
09:44am, Monday, 02'nd Mar 2020
BioTelemetry Inc (NASDAQ:BEAT) saw a large increase in short interest in the month of February. As of February 14th, there was short interest totalling 3,040,000 shares, an increase of 7.4% from the J
BioTelemetry Inc (NASDAQ:BEAT) Expected to Earn FY2021 Earnings of $2.27 Per Share
09:32am, Monday, 02'nd Mar 2020
BioTelemetry Inc (NASDAQ:BEAT) – Equities researchers at Dougherty & Co issued their FY2021 earnings per share estimates for shares of BioTelemetry in a note issued to investors on Thursday, Februar
Pokemon Go: Tricks and Counter Tips on How to Beat Nidorino in Raid!
01:38am, Monday, 02'nd Mar 2020
Raid bosses are usually tough, but there are specific weaknesses to every single one of them! Nidorino in Pokemon Go is no exemption to this list. Find out how to beat this raid boss easily!
Los Angeles Capital Management & Equity Research Inc. Cuts Stock Position in BioTelemetry Inc (NASDAQ:BEAT)
10:58am, Sunday, 01'st Mar 2020
Los Angeles Capital Management & Equity Research Inc. cut its holdings in shares of BioTelemetry Inc (NASDAQ:BEAT) by 25.0% during the fourth quarter, Holdings Channel reports. The firm owned 5,663 sh
BioTelemetry (NASDAQ:BEAT) Lowered to "Sell" at Zacks Investment Research
10:18am, Sunday, 01'st Mar 2020
Zacks Investment Research downgraded shares of BioTelemetry (NASDAQ:BEAT) from a hold rating to a sell rating in a research note issued to investors on Wednesday morning, Zacks.com reports. According
BioTelemetry (NASDAQ:BEAT) Cut to C at TheStreet
10:00am, Saturday, 29'th Feb 2020
TheStreet cut shares of BioTelemetry (NASDAQ:BEAT) from a b- rating to a c rating in a research report sent to investors on Wednesday morning, TheStreetRatingsTable reports. BEAT has been the subject
BioTelemetry Inc Expected to Post Q1 2020 Earnings of $0.45 Per Share (NASDAQ:BEAT)
07:16am, Saturday, 29'th Feb 2020
BioTelemetry Inc (NASDAQ:BEAT) – Research analysts at SunTrust Banks decreased their Q1 2020 earnings per share estimates for BioTelemetry in a report issued on Wednesday, February 26th. SunTrust Ba
The "Global Telemedicine Market 2020-2024" report has been added to ResearchAndMarkets.com's offering.
Dougherty & Co Weighs in on BioTelemetry Inc's Q1 2020 Earnings (NASDAQ:BEAT)
11:42am, Friday, 28'th Feb 2020
BioTelemetry Inc (NASDAQ:BEAT) – Stock analysts at Dougherty & Co issued their Q1 2020 earnings per share estimates for shares of BioTelemetry in a research report issued on Thursday, February 27th.
BioTelemetry (NASDAQ:BEAT) Trading Down 6.2% Following Analyst Downgrade
07:38am, Friday, 28'th Feb 2020
BioTelemetry Inc (NASDAQ:BEAT) was down 6.2% during trading on Thursday after Sidoti lowered their price target on the stock from $81.00 to $75.00. Sidoti currently has a buy rating on the stock. BioT
Sidoti & Co. Maintains Buy on BioTelemetry, Lowers Price Target to $75
03:08pm, Thursday, 27'th Feb 2020Zacks: Brokerages Expect BioTelemetry Inc (NASDAQ:BEAT) Will Announce Quarterly Sales of $110.35 Million
09:20am, Thursday, 27'th Feb 2020
Analysts expect BioTelemetry Inc (NASDAQ:BEAT) to report sales of $110.35 million for the current quarter, Zacks reports. Three analysts have made estimates for BioTelemetry’s earnings, with the hig
